SCHEMBL17055653

SCHEMBL17055653

CCNC(=O)N1CCCC(F)(F)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
HTT P42858 1/20 0.46
ALDH1A1 P00352 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
DPP4 P27487 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
EPHX2 P34913 2/20 0.36
VNN1 O95497 1/20 0.36
EPHX1 P07099 1/20 0.36
LMNA P02545 1/20 0.36
RORC P51449 2/20 0.36
MAPK1 P28482 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20307157 0.90 KMT2A (0.57) KMT2AHTTALDH1A1CYP2C9CYP1A2
SCHEMBL24664430 0.82 KMT2A (0.59) KMT2AHTTCYP2D6DPP4RORC
SCHEMBL17035434 0.81 POLB (0.48) ALDH1A1CYP2C9CYP1A2CYP2D6HDAC3
SCHEMBL17032813 0.79 CYP1A2 (0.57) ALDH1A1CYP2C9CYP1A2CYP2D6TSHR
SCHEMBL14617960 0.77 ALDH1A1 (0.44) KMT2AALDH1A1DPP4DPP7EPHX2
SCHEMBL17034780 0.77 LMNA (0.42) ALDH1A1CYP2C9CYP1A2CYP2D6HDAC3
SCHEMBL965286 0.76 KMT2A (0.82) KMT2AHTTALDH1A1EPHX2LMNA
SCHEMBL19741751 0.76
SCHEMBL17176083 0.75 KMT2A (0.61) KMT2AHTTALDH1A1CYP2D6EPHX2
SCHEMBL17039080 0.75 TSHR (0.43) HTTALDH1A1CYP2C9CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015130795-A1 AMIDE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2015-09-03 WO disclosed